× About the Journal Scope of the Journal SPER Publications Editorial Board Abstracting and Indexing Articles in Press Current Issue Archives Conference Proceedings Submit Article Author Guidelines Advertise Join as Reviewer Contact Publishing Ethics


 
Year : 2017   |  Volume : 7  |  Issue : 3  |  Page : 212-215

Protocols for use of biologics in oral diseases
Biologics are used in the treatment of immune-mediated diseases with the aim of modulating lymphocytes or cytokines. They can be categorized broadly into three categories: Tumor necrosis factor-alpha inhibitors, lymphocyte modulators, and interleukin inhibitors. Guidelines for the development of biologics include validations of various steps in development, standard guidelines, regulatory guidelines, manufacturing guidelines, and analytical tests. Hence, in this article, the guidelines and key aspects of guidelines in the use of biologics in oral diseases are presented.
Print this article     Email this article

 

Contact SPER Publications


SPER Publications and Solutions Pvt. Ltd.

HD - 236,
Near The Shri Ram Millenium School,
Sector 135,
Noida-Greater Noida Expressway,
Noida-201301 [Delhi-NCR] India